These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38312121)

  • 1. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
    Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
    World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer.
    Akabane S; Shimizu W; Takakura Y; Kochi M; Taguchi K; Nakashima I; Sato K; Hattori M; Egi H; Sentani K; Yasui W; Ohdan H
    Int J Clin Oncol; 2021 Jul; 26(7):1285-1292. PubMed ID: 33881678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
    González IA; Bauer PS; Liu J; Chatterjee D
    Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer.
    Gan T; Schaberg KB; He D; Mansour A; Kapoor H; Wang C; Evers BM; Bocklage TJ
    JAMA Netw Open; 2021 Apr; 4(4):e213897. PubMed ID: 33792733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
    Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
    Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
    Archilla I; Díaz-Mercedes S; Aguirre JJ; Tarragona J; Machado I; Rodrigo MT; Lopez-Prades S; Gorostiaga I; Landolfi S; Alén BO; Balaguer F; Castells A; Camps J; Cuatrecasas M
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00303. PubMed ID: 33939382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
    Bruun J; Sveen A; Barros R; Eide PW; Eilertsen I; Kolberg M; Pellinen T; David L; Svindland A; Kallioniemi O; Guren MG; Nesbakken A; Almeida R; Lothe RA
    Mol Oncol; 2018 Sep; 12(9):1639-1655. PubMed ID: 29900672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer.
    Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC
    Med Clin (Barc); 2024 Aug; 163(4):159-166. PubMed ID: 38697893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
    Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer.
    Mitrovic B; Handley K; Assarzadegan N; Chang HL; Dawson HAE; Grin A; Hutchins GGA; Magill L; Quirke P; Riddell RH; Gray RG; Kirsch R;
    Clin Colorectal Cancer; 2021 Sep; 20(3):256-264. PubMed ID: 34099382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.